Gene Expression Analysis Market Report by Products & Services (Consumables, Instruments, Services), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), DNA Microarray, Sanger Sequencing, and Others), Capacity (Low-to Mid-Plex Gene Expression Analysis, High-Plex Gene Expression Analysis), End-User (Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others), and Region 2025-2033

Gene Expression Analysis Market Report by Products & Services (Consumables, Instruments, Services), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), DNA Microarray, Sanger Sequencing, and Others), Capacity (Low-to Mid-Plex Gene Expression Analysis, High-Plex Gene Expression Analysis), End-User (Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1832

Market Overview:

The global gene expression analysis market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.21% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 5.6 Billion
Market Forecast in 2033
USD 11.7 Billion
Market Growth Rate (2025-2033) 8.21%


Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gene expression analysis market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on products & services, technology, capacity and end-user.

Breakup by Products & Services:

  • Consumables
  • Instruments
  • Services
     

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • DNA Microarray
  • Sanger Sequencing
  • Others
     

Breakup by Capacity:

  • Low-to Mid-Plex Gene Expression Analysis
  • High-Plex Gene Expression Analysis
     

Breakup by End-User:

  • Pharmaceutical and Biotech Companies
  • Academic Institutes and Research Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others


Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Products & Services, Technology, Capacity, End-User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru ,Turkey, Saudi Arabia, Iran, United Arab Emirates
Companies Covered Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH and Thermo Fisher Scientific Inc., etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global gene expression analysis market was valued at USD 5.6 Billion in 2024.

We expect the global gene expression analysis market to exhibit a CAGR of 8.21% during 2025-2033.

The rising adoption of targeted molecular therapeutics, along with the growing prevalence of genetic disorders, is primarily driving the global gene expression analysis market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of gene expression analysis, as it aids in improving the functionality of the existing diagnostic methods and developing novel drugs against the coronavirus infection.

Based on the product & services, the global gene expression analysis market has been divided into consumables, instruments, and services. Among these, consumables currently exhibit a clear dominance in the market.

Based on the technology, the global gene expression analysis market can be categorized into Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), DNA microarray, sanger sequencing, and others. Currently, DNA microarray accounts for the majority of the global market share.

Based on the capacity, the global gene expression analysis market has been segregated into low-to mid-plex gene expression analysis and high-plex gene expression analysis, where high-plex gene expression analysis currently exhibits a clear dominance in the market.

Based on the end-user, the global gene expression analysis market can be bifurcated into pharmaceutical and biotech companies, academic institutes and research centers, and others. Currently, pharmaceutical and biotech companies hold the largest market share.

On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global gene expression analysis market include Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Gene Expression Analysis Market Report by Products & Services (Consumables, Instruments, Services), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), DNA Microarray, Sanger Sequencing, and Others), Capacity (Low-to Mid-Plex Gene Expression Analysis, High-Plex Gene Expression Analysis), End-User (Pharmaceutical and Biotech Companies, Academic Institutes and Research Centers, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials